-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Spectrum Pharmaceuticals Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2022.
- Spectrum Pharmaceuticals Inc Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2023 was -$5.01M, a 67.6% increase year-over-year.
- Spectrum Pharmaceuticals Inc Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2023 was -$65M, a 53.1% increase year-over-year.
- Spectrum Pharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$75.4M, a 52.5% increase from 2021.
- Spectrum Pharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2021 was -$159M, a 1.39% increase from 2020.
- Spectrum Pharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2020 was -$161M, a 42.8% decline from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)